Analytical Data
-
Gene name
PDLIM3
- Application
-
Alternative Names
Actinin-associated LIM protein;Alpha-actinin-2-associated LIM protein
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q53GG5
-
Expression Region
1-189aa
-
Molecular Weight
36.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PDLIM3, a member of the PDZ-LIM domain protein family, has garnered significant attention in recent years due to its roles in various cellular processes, including cytoskeletal organization, gene expression regulation, and cell signaling. This protein is characterized by its PDZ and LIM domains, which facilitate protein-protein interactions critical for cellular function. Research has shown that PDLIM3 is involved in the regulation of muscle development and differentiation, as well as influencing the behavior of various cell types in response to external stimuli. Moreover, aberrant expression of PDLIM3 has been implicated in several pathological conditions, including cancer and cardiovascular diseases, underscoring its potential as a biomarker and therapeutic target. The study of PDLIM3 recombinant protein is essential for elucidating its mechanisms of action and exploring its interactions with other cellular proteins. By producing and characterizing PDLIM3 in a recombinant form, researchers aim to gain insights into its structural properties and functional implications, paving the way for potential applications in disease treatment and biomarker development. Overall, the exploration of PDLIM3 through recombinant protein studies holds promise for advancing our understanding of its biological significance and therapeutic potential.
